EZH2 and neoplasm: As expected, administration of DZNep, which depleted EZH2 and MYCN, markedly inhibited proliferation of all the tumor cells examined, while administration of the enzymatic inhibitors (GSK126 and EPZ6438) exhibited minimal effects on Kelly and BE-2C cells (Fig. 5b and Supplementary Fig. 5b).